Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has informed the stock exchanges about a scheduled meeting with Sowilo Investment Managers on September 2, 2025. The meeting will be held virtually in a one-on-one format and attended by company representatives. The disclosure is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. The filing notes that the schedule may change due to exigencies on the part of the investor, analyst, or the company.
This is a routine regulatory disclosure with no direct impact on stock price. It signals normal investor engagement activity, which is generally viewed as a positive corporate governance practice.